“We are pleased to give Congress attendees this unique opportunity to get hands-on experience with these exciting developments from our Innovation Lab,” said Ron Sullivan, Executive Vice President, eCOA at ERT.
Philadelphia, PA (PRWEB) August 31, 2015
ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions will demonstrate multiple prototypes from its Innovation Lab during its 8th Annual European PRO and eCOA Congress in Lisbon, Portugal, September 22-24, 2015. This is the only European event dedicated to providing case studies and pragmatic information on the clinical science, regulatory and innovative technologies used to collect patient safety and efficacy data during clinical development. Registration for the European Congress can be found here.
Congress attendees will participate in large and small group discussions led by international thought leaders in the areas of Patient Reported Outcomes (PRO) and electronic Clinical Outcome Assessments (eCOA) data capture. The PRO and eCOA Congress covers a broad range of topics pertaining to the current PRO / eCOA environment, including the BYOD debate, regulatory perspectives on eSource, rater training and centralized rater performance monitoring.
ERT will also give Congress attendees a first-hand look at select concepts currently in beta testing at its Boston-based Innovation Lab. The Innovation Lab is ERT’s state-of-the-art facility where dedicated scientists and technological experts collaborate with partners in developing new technologies that enhance the collection of patient research data. Examples of concepts that will be demonstrated at the Congress include:
- eCOAStudy Designer for Rapid Prototyping
- Localization Tool with Translation Preview
- ECG with Fall Detection and Pulse Rate Diary Integration
- Bluetooth Blood Pressure Cuffs Comparison
- CleverCap™ Medication Dispensing
Innovation Lab prototypes will also be demonstrated at ERT’s U.S. PRO / eCOA Congress, which takes place October 27-29, 2015 in Washington, DC. Additional information and registration can be found here.
“We are pleased to give Congress attendees this unique opportunity to get hands-on experience with these exciting developments from our Innovation Lab,” said Ron Sullivan, Executive Vice President, eCOA at ERT. “Both the European and US Congress events will disclose prototypes and other initiatives for our industry – an opportunity normally reserved for Innovation Lab visitors.”
For additional on ERT’s Innovation Lab, visit https://www.ert.com/innovation-lab.
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle. ERT delivers the most widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Switzerland, Japan and Germany. Join ERT on Facebook, LinkedIn, Twitter, and YouTube.